Cashu
Castle Biosciences Advances Melanoma Diagnostics with DecisionDx-Melanoma at AAD Annual Meeting
5 days ago
Stocks
Health Care
cstl
Castle Biosciences
NASDAQ: CSTL
-0.21 (-0.84%)
24.84
USD
At close at Apr 03, 20:40 UTC
Overview
Loading chart...
Key Stats
Market Cap
725.05M
Dividend Yield
0.00%
P/E Ratio
-30.01
EPS
0.66
Revenue
332.07M
Avg. Volume
324.82K
About
What does CSTL do?
Castle Biosciences, headquartered in Friendswood, Texas, is a dermatological cancer company that provides genomic tests for skin cancers and mental health conditions. The firm went public in July 2019 and employs 610 people.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.